Boehringer Ingelheim Posts Sales Growth as Obesity Drug Filing Awaits
10 hours ago
2
Boehringer Ingelheim’s top-selling cause lifted income successful the archetypal half, arsenic the German drugmaker gears up to record for U.S. support of a caller obesity medicine.